STRUCTURE OF HUMAN GLP-1(GLUCAGON-LIKE PEPTIDE-1) CONTAINING PEPTIDES

被引：0
|
作者：
ORSKOV, C
KOFOD, H
RABENHOJ, L
WETTERGREN, A
HOLST, JJ
机构：
[1] UNIV COPENHAGEN,PANUM INST,DEPT MED PHYSIOL C,DK-2200 COPENHAGEN,DENMARK
[2] UNIV COPENHAGEN,RIGSHOSP,DEPT CLIN CHEM,DK-2100 COPENHAGEN,DENMARK
[3] UNIV COPENHAGEN,RIGSHOSP,DEPT SURG C,DK-2100 COPENHAGEN,DENMARK
来源：
DIABETOLOGIA | 1992年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A109 / A109
页数：1
相关论文
共 50 条
  • [21] An improved procedure for measurement of total glucagon-like peptide-1 (GLP-1) in human plasma
    Tanen, M
    Snyder, K
    Dallob, A
    Herman, G
    Wagner, J
    Gottesdiener, K
    Tanaka, W
    CLINICAL CHEMISTRY, 2004, 50 (06) : A107 - A107
  • [22] Glucagon-like peptide 1 (GLP-1) and eating
    Gutzwiller, JP
    Degen, L
    Heuss, L
    Beglinger, C
    PHYSIOLOGY & BEHAVIOR, 2004, 82 (01) : 17 - 19
  • [23] Discovery of novel cyclic peptides which exhibit glucagon-like peptide-1 (GLP-1) receptor agonism
    Limberakis, Chris
    Aspnes, Gary
    Derksen, David
    Edmonds, David
    Eng, Heather
    Fairlie, David
    Goetz, Gilles
    Gopalsamy, Ariamala
    Griffith, David
    Hill, Timothy
    Huy Hoang
    Kalgutkar, Amit
    Kok, W.
    Liras, Spiros
    Mascitti, Vincent
    Mathiowetz, Alan
    Mitchell, Justin
    Piotrowski, David
    Price, David
    Rotter, Charles
    Ruggeri, Roger
    Song, Kun
    Stanton, Robert
    Suen, Jacky
    Withka, Jane
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [24] Can glucagon-like peptide-1(GLP-1) analogues make neuroprotection a reality?
    Maryna V.Basalay
    Sean M.Davidson
    Derek M.Yellon
    NeuralRegenerationResearch, 2020, 15 (10) : 1852 - 1853
  • [25] Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
    Unger J.R.
    Parkin C.G.
    Diabetes Therapy, 2011, 2 (1) : 29 - 39
  • [26] Glucagon-like peptide-1 (GLP-1) action in the mouse area postrema neurons
    Kawatani, Masahiro
    Yamada, Yuichiro
    Kawatani, Masahito
    PEPTIDES, 2018, 107 : 68 - 74
  • [27] Metabolic responses and benefits of glucagon-like peptide-1 (GLP-1) receptor ligands
    Tanday, Neil
    Flatt, Peter R.
    Irwin, Nigel
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 526 - 541
  • [28] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
    Li, Ya-Kun
    Ma, Dong-Xia
    Wang, Zhi-Min
    Hu, Xiao-Fan
    Li, Shang-Lin
    Tian, Hong-Zhe
    Wang, Meng-Jun
    Shu, Yan-Wen
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 102 - 111
  • [29] Somatostatin is a major, paracrine regulator of glucagon-like peptide-1 (GLP-1) secretion
    Hansen, L
    Mineo, H
    Bisgaard, T
    Jorgensen, PN
    Holst, JJ
    DIABETOLOGIA, 1997, 40 : 498 - 498
  • [30] Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
    Abba J. Kastin
    Victoria Akerstrom
    Weihong Pan
    Journal of Molecular Neuroscience, 2002, 18 : 7 - 14
12345